Spruce Biosciences (SPRB) stock Forecast for 2022 – 2026
Last update: 05-28-2022, 9:22Sector: Healthcare
The share price of Spruce Biosciences, Inc. (SPRB) now
What analysts predict:: $9.17
52-week high/low: $15.08 / $1.25
50/200 Day Moving Average: $1.859 / $3.801
This figure corresponds to the average price over the previous 50/200 days. For Spruce Biosciences stocks, the 50-day moving average is the resistance level today.
For Spruce Biosciences stocks, the 200-day moving average is the resistance level today.
Are you interested in Spruce Biosciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Spruce Biosciences stock price in 2022, 2023, 2024, 2025, 2026. How much will one Spruce Biosciences share be worth in 2022 - 2026?
When should I take profit in Spruce Biosciences stock? When should I record a loss on Spruce Biosciences stock? What are analysts' forecasts for Spruce Biosciences stock? What is the future of Spruce Biosciences stock?
We forecast Spruce Biosciences stock performance using neural networks based on historical data on Spruce Biosciences stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Spruce Biosciences stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Spruce Biosciences shares. This happens once a day.
Historical and forecast chart of Spruce Biosciences stock
The chart below shows the historical price of Spruce Biosciences stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Spruce Biosciences stock price can be found in the table below.
Long-term forecasts by years.
Spruce Biosciences daily forecast for a month
Spruce Biosciences Daily Price Targets
Spruce Biosciences Stock Forecast 05-30-2022.
Pessimistic target level: 1.46
Optimistic target level: 1.55
Spruce Biosciences Stock Forecast 05-31-2022.
Pessimistic target level: 1.48
Optimistic target level: 1.58
Spruce Biosciences Stock Forecast 06-01-2022.
Pessimistic target level: 1.53
Optimistic target level: 1.58
Spruce Biosciences Stock Forecast 06-02-2022.
Pessimistic target level: 1.53
Optimistic target level: 1.61
Spruce Biosciences Stock Forecast 06-03-2022.
Pessimistic target level: 1.54
Optimistic target level: 1.65
Spruce Biosciences Stock Forecast 06-04-2022.
Pessimistic target level: 1.50
Optimistic target level: 1.60
SPRB (SPRB) Monthly Stock Prediction for 2022
Spruce Biosciences forecast for this year
Spruce Biosciences Stock Prediction for Jun 2022
An downtrend is forecast for this month with an optimal target price of $1.30181. Pessimistic: $1.20. Optimistic: $1.35
Spruce Biosciences Stock Prediction for Jul 2022
An uptrend is forecast for this month with an optimal target price of $1.46115. Pessimistic: $1.40. Optimistic: $1.53
Spruce Biosciences Stock Prediction for Aug 2022
An downtrend is forecast for this month with an optimal target price of $1.44624. Pessimistic: $1.31. Optimistic: $1.52
Spruce Biosciences Stock Prediction for Sep 2022
An downtrend is forecast for this month with an optimal target price of $1.27414. Pessimistic: $1.12. Optimistic: $1.33
Spruce Biosciences Stock Prediction for Oct 2022
An downtrend is forecast for this month with an optimal target price of $1.25681. Pessimistic: $1.12. Optimistic: $1.36
Spruce Biosciences Stock Prediction for Nov 2022
An uptrend is forecast for this month with an optimal target price of $1.33373. Pessimistic: $1.22. Optimistic: $1.51
Spruce Biosciences Stock Prediction for Dec 2022
An uptrend is forecast for this month with an optimal target price of $1.35413. Pessimistic: $1.24. Optimistic: $1.48
Spruce Biosciences (SPRB) Monthly Stock Prediction for 2023
Spruce Biosciences (SPRB) Monthly Stock Prediction for 2024
Spruce Biosciences (SPRB) Monthly Stock Prediction for 2025
Spruce Biosciences (SPRB) Monthly Stock Prediction for 2026
Spruce Biosciences information and performance
The company has developed a candidate product, tildaserfont, as the first potential non-steroidal therapy for the treatment of congenital adrenal hyperplasia. Congenital adrenal hyperplasia belongs to the group of hereditary diseases. People have two adrenal glands, each located at the top of each kidney. These glands produce the hormones cortisol and aldosterone, which play an important role in the body. People with congenital hyperplasia of the adrenal cortex do not synthesize the enzyme necessary for the production of hormones.
Spruce Biosciences Address
2001 JUNIPERO SERRA BLVD., SUITE 640, DALY CITY, CA, US
Market Capitalization: 31 715 400 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: - $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: None
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: -
Enterprise Value (EV) /Revenue
EV To EBITDA: 1.216
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 23492900
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.